Peptide Research Guides
Educational database of peptides with information on mechanisms, research status, and safety profiles. For research purposes only.
Showing 20 of 20 peptides
BPC-157
Body Protection Compound-157, a synthetic peptide derived from human gastric juice protein. Studied for tissue repair, gut healing, and anti-inflammatory effects.
- • No human trials
- • Banned by WADA
TB-500
Thymosin Beta-4 fragment studied for cellular regeneration and wound healing. Part of the popular 'Wolverine Stack' combination.
- • Cancer pathway concerns
- • Banned by WADA
Semaglutide
GLP-1 receptor agonist approved for type 2 diabetes and chronic weight management. Sold as Ozempic and Wegovy.
- • Requires prescription
- • GI side effects common
Tirzepatide
Dual GIP/GLP-1 receptor agonist approved for diabetes and obesity. Sold as Mounjaro and Zepbound.
- • Requires prescription
- • Supply shortages
Retatrutide
Triple hormone receptor agonist (GLP-1/GIP/Glucagon) in clinical trials. Called 'GLP-3' on gray market despite not being approved.
- • Not FDA approved
- • Gray market versions untested
Ipamorelin
Growth hormone releasing peptide (GHRP) that stimulates natural GH production without affecting cortisol or prolactin.
- • FDA flagged for safety risks
- • No approved use
CJC-1295
Growth hormone releasing hormone (GHRH) analog often combined with Ipamorelin for synergistic effects.
- • FDA flagged for safety risks
- • Requires injection
Melanotan II
Synthetic analog of alpha-melanocyte-stimulating hormone that increases melanin production for skin tanning.
- • Banned by WADA
- • Mole changes risk
- • Cardiovascular effects
GHK-Cu
Copper peptide naturally found in human plasma. Studied for wound healing, skin regeneration, and anti-aging effects.
- • Limited human data
- • Topical vs injectable debate
Epitalon
Synthetic tetrapeptide studied for telomerase activation and potential anti-aging effects. Popular in longevity circles.
- • Very limited research
- • No human trials
Semax
Synthetic peptide derived from ACTH. Approved in Russia for stroke and cognitive enhancement.
- • Not FDA approved
- • Limited Western research
Selank
Synthetic peptide with anxiolytic properties. Approved in Russia for anxiety and nootropic effects.
- • Not FDA approved
- • Limited Western research
Orforglipron
The most anticipated upcoming weight loss drug - the first oral non-peptide GLP-1 receptor agonist. No fasting required.
- • Not FDA approved
- • Approval timeline remains uncertain; monitor FDA updates
CagriSema
Next-gen combination of semaglutide + cagrilintide by Novo Nordisk. Aims for stronger weight loss than Wegovy alone.
- • Not FDA approved
- • Approval timeline remains uncertain pending trial outcomes
Tesamorelin
FDA-approved GHRH analog for HIV lipodystrophy. Increasingly used off-label for abdominal fat reduction.
- • Requires prescription
- • Expensive
- • WADA banned
AOD-9604
Fragment of human growth hormone marketed for fat burning. Now banned from compounding by FDA.
- • Banned from compounding
- • Limited efficacy data
- • WADA banned
5-Amino-1MQ
Small molecule targeting visceral fat by inhibiting NNMT enzyme. Boosts NAD+ levels and metabolic rate.
- • Very limited human data
- • Theoretical mechanism
MOTS-c
Mitochondrial peptide described as an 'exercise mimetic' - may improve glucose metabolism and stamina without training.
- • Very limited human data
- • Expensive
FOXO4-DRI
Promising senolytic peptide that clears senescent 'zombie' cells. Showed dramatic anti-aging results in mice.
- • Only animal studies
- • Extremely expensive
- • Theoretical cancer concerns
Tesofensine
Triple monoamine reuptake inhibitor with potent appetite suppression. Originally developed for Parkinson's.
- • CNS stimulant effects
- • Cardiovascular concerns
- • Not FDA approved
Important Disclaimer
This information is for educational purposes only and should not be considered medical advice. Many peptides listed here are not FDA-approved for human use and may carry significant health risks. Always consult with qualified healthcare professionals before considering any peptide use.